Pharmaceutical sales jumped 7.7% in the quarter to $16.76 billion, but medical technology division sales rose just 2.5% to $8.6 billion.
같은 분류의 다른 기사
We're upgrading our rating on Wells Fargo as the stock's pullback offers a nice entry point- We're upgrading our Goldman Sachs rating after a strong quarter bodes well for the future
- J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
- Bank earnings takeaways: Here's how JPMorgan, Goldman, Wells Fargo and Citi performed in Q3